文献速递腹部介入CTMRUS

对比增强超声在融合引导经皮肝局灶性病变活检中的附加价值:前瞻性可行性研究

Additional value of contrast-enhanced ultrasonography for fusion-guided, percutaneous biopsies of focal liver lesions: prospective feasibility study.
PubMed 文献 · Abdom Radiol (NY) · 2018-01-01

前瞻性纳入40例CT/MRI发现肝局灶性病变的患者,比较USG-Fusion与CEUS-Fusion对病灶可见性、操作成功信心及安全路径可及性的影响。CEUS-Fusion使9例USG-Fusion不可见病灶中7例(77.8%)可见,操作信心显著提高(p=0.02),40%患者预设靶点改变,39例(97.5%)获得确诊诊断结果。

要点

  • CEUS-Fusion可使USG-Fusion不可见的肝病灶中77.8%(7/9)变为可见。
  • CEUS-Fusion较USG-Fusion显著提高操作技术成功的信心(p=0.02)。
  • CEUS-Fusion后40%(16/40)患者预设活检靶点发生改变。

核心结论

  • 与常规USG-Fusion相比,实时CEUS-Fusion联合CT/MRI可改善肿瘤可见性和活性部分评估,从而提高操作者信心和诊断率。

研究设计与样本

  • 前瞻性可行性研究,纳入40例CT/MRI发现肝局灶性病变的患者,行USG-Fusion及CEUS-Fusion并与CT/MRI融合进行活检规划;研究经机构审查委员会批准并获得书面知情同意。

关键影像表现/征象

  • 40个目标病灶中,9个(22.5%)在USG-Fusion上不可见。
  • 应用CEUS-Fusion后,9个不可见病灶中7个(77.8%)变为可见。
  • CEUS-Fusion后,16例(40%)患者的预设靶点发生改变。
  • 病灶坏死时,CEUS-Fusion后预设靶点改变更频繁(50.0%和25.0%)。

诊断标准与关键数值

  • CEUS-Fusion较USG-Fusion显著提高操作技术成功的信心水平(p=0.02)。
  • CEUS-Fusion与USG-Fusion在安全路径可及性方面未达到统计学差异。
  • 39例(97.5%)患者获得确诊性诊断结果。

临床应用与阅片要点

  • 对于USG-Fusion不可见的肝局灶性病变,可尝试CEUS-Fusion以改善病灶可见性。
  • CEUS-Fusion有助于评估病灶活性部分,可能改变预设活检靶点。
  • CEUS-Fusion可提高操作者对技术成功的信心。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To determine the value of CEUS for real-time, fusion-guided, percutaneous biopsies of focal liver lesions.

MATERIALS AND METHODS: Institutional review board approval and written informed consents were obtained for this study. Forty patients with focal liver lesions identified on CT/MRI were prospectively enrolled. For biopsy planning, real-time fusion of CT/MRI with USG (USG-Fusion) was performed, and subsequently real-time CEUS was fused with CT/MRI (CEUS-Fusion). We evaluated lesion visibility, confidence level of technical success before the procedure, and safety route accessibility on USG-Fusion and CEUS-Fusion. Occurrence of change in the biopsy target was also assessed.

RESULTS: Among 40 target lesions, nine (22.5%) lesions were invisible on USG-Fusion. After applying CEUS-Fusion, seven of nine (77.8%) lesions were visualized. Confidence level of technical success of procedure was significantly increased on CEUS-Fusion compared USG-Fusion (p = 0.02), and presumed target lesions were changed in 16 (40%) patients after CEUS-Fusion. As the lesion is necrotic, presumed target was more frequently changed after CEUS-Fusion (50.0% and 25.0%). Confirmative diagnostic results were reported in 39 (97.5%) patients. Accessibility of the safety route to target lesions did not reach statistical differences.

CONCLUSION: Applying a new, real-time CEUS-Fusion with CT/MRI improved tumor visibility and viable portion assessment, thus leading to higher operator confidence and diagnostic yield, when compared with conventional USG-Fusion.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Kang HJ, Kim JH, Lee SM, et al. Additional value of contrast-enhanced ultrasonography for fusion-guided, percutaneous biopsies of focal liver lesions: prospective feasibility study. Abdom Radiol (NY). 2018. PMID: 29671007. doi:10.1007/s00261-018-1608-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。